Literature DB >> 156220

DRw antisera react with activated T cells.

W C DeWolf, S F Schlossman, E J Yunis.   

Abstract

Nylon wool-purified T cells appear to be nonreactive in a lymphocytotoxicity assay with HLA-DRw antisera and complement before cell activation. However, after activation in mixed lymphocyte culture, responder cells express determinants that are strongly reactive with DRw alloantisera after 6 days and gradually disappear by 16 to 18 days. Restimulation of the primed cells resulted in re-expression of the blast determinants. Mitogenic stimulation with Con A or purified PHA (HA-17) also resulted in temporary expression of these determinants; reactivity usually conformed to DRw genetic restriction; however, occasional extra reactions occurred that were variable depending on the method of activation (i.e., MLC, Con A, or HA-17). The results suggest the presence of additional allospecificities within some of the DRw antisera that react with "Ia-like" antigens on activated cells from unique subsets of T cells. Whether these DRw antisera contain antibodies against T cells or agains activation or differentiation T cell antigens is not as yet clear.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156220

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways.

Authors:  Roberto Spreafico; Maura Rossetti; John W Whitaker; Wei Wang; Daniel J Lovell; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

2.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens.

Authors:  M Gerbase de Lima; E E Wollman; V Lepage; L Degos; J Dausset
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.

Authors:  S V Fuggle; J Kirkley; A Ting; P J Morris
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

7.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.

Authors:  T Cotner; J M Williams; L Christenson; H M Shapiro; T B Strom; J Strominger
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

8.  A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment.

Authors:  Roberto Spreafico; Maura Rossetti; Jorg van Loosdregt; Carol A Wallace; Margherita Massa; Silvia Magni-Manzoni; Marco Gattorno; Alberto Martini; Daniel J Lovell; Salvatore Albani
Journal:  Ann Rheum Dis       Date:  2014-12-12       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.